Friday, 25 May 2018

You are here

Linkage Between Gut and Joint Immunity in Rheumatoid Arthritis

Pianta, et al have published their findings in the Journal of Clinical Investigation showing that two novel autoantigens, GNS and FLNA, are highly expressed in synovium and share a sequence homology with gut microbesa; thereby providing a potential link between gut mucosal and joint immunity in rheumatoid arthritis (RA). 

Researchers used discovery-based proteomics to detect HLA-DR–presented peptides in synovia or peripheral blood mononuclear cells from RA patients. They found that two autoantigens, N-acetylglucosamine-6-sulfatase (GNS) and filamin A (FLNA), yielded effective T and B cell antigen specific responses (52% and 56%, respectively).

GNS and FLNA are highly expressed in synovia. GNS appeared to be citrullinated, and GNS antibody values correlate with ACPA levels. FLNA was different and did not show the same results.

The GNS peptide has marked sequence homology with epitopes from Prevotella sp. and Parabacteroides sp.

FLNA peptide has homology with epitopes from Prevotella sp. and Butyricimonas sp.

Reactivity to either GNS or FLNA was associated with reactivity to the corresponding microbial peptides.

Also, binding of these self- and microbial peptides and their responses were more common in RA patients with SE alleles.

The homology and cross reactivity of these two self-proteins and corresponding gut microbes may provide a link between mucosal and joint immunity in patients with RA.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Autoinflammatory Syndromes Show Dramatic Response to Canakinumab

The New England Journal of Medicine reports that the anti-interleukin (IL)-1β monoclonal antibody canakinumab (Ilaris) was effective in the treatment of three distinct autoinflammatory recurrent fever syndromes (FMF, TRAPS, HIDS) with responses that were far superior to what was seen with placebo on almost every outcome measure, a randomized study found.

Treat-to-Target a Bust with Rheumatologists

Treat-to-target strategy is widely advocated as an important means of optimizing treatment responses in patients with rheumatoid arthritis. Even though T2T is encouraged by most guidelines, a current report shows that US Rheumatologists fail to implement T2T in their daily practice.

Epigenetic Link in Rheumatoid Arthritis to Huntington's Disease

Researchers at University of California San Diego School and the Icahn School of Medicine have found a high-resolution epigenomic landscape of rheumatoid arthritis (RA) that overlaps with that seen in Huntington's disease, suggesting potentially new unanticipated pathways that could be developed into therapeutic targets.

Mortality Predictors in Rheumatoid Arthritis

A population based study from southern Denmark finds excess mortality RF-positive males with rheumatoid arthritis (RA) and that employment status and comorbidity were independent predictors of mortality.

Investigators stuided 509 RA patients between 1995 to 2002, of whom 200 (39%) died during 6079 person-years of follow-up.

Genetic Breakthrough in Systemic JIA

The identification of a genetic susceptibility locus for systemic juvenile idiopathic arthritis (sJIA) has important implications for treatment of this severe, poorly understood illness, researchers reported.